Odile Fenneteau

Odile Fenneteau

Auto-generated profile, based on publicly available information

Odile Fenneteau

French-Speaking Cellular Hematology Group, 69500 Bron, France

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2021 in Cancers
Verified
Journal Article
Open access
PDF file
CCCharlotte Calvo
Charlotte Calvo
OFOdile Fenneteau
Odile Fenneteau
GLGuy Leverger
Guy Leverger
APArnaud Petit
Arnaud Petit
ABAndré Baruchel
André Baruchel
FMFrançoise Méchinaud
Françoise Méchinaud
Infant acute myeloid leukemia (AML) is a rare subgroup of AML of children <2 years of age. It is as frequent as infant acute lymphoblastic leukemia (ALL) but not clearly distinguished by study groups. However, infant AML demonstrates peculiar clinical and biological characteristics, and its prognosis differs from AML in older children. Acute megakaryoblastic leukemia (AMKL) is very frequent in this age group and has raised growing interest. Thus, AMKL is a dominant topic in this review. Recent genomic sequencing has contributed to our understanding of infant AML. These data demonstrated striking features of infant AML: fusion genes are able to induce AML transformation without additional cooperation, and unlike AML in older age groups there is a paucity of associated mutations. Mice modeling of these fusions showed the essential role of ontogeny in the infant leukemia phenotype compared to older children and adults. Understanding leukemogenesis may help in developing new targeted treatments to improve outcomes that are often very poor in this age group. A specific diagnostic and therapeutic approach for this age group should be investigated.

28 February 2022 in Genes
Verified
Journal Article
Open access
PDF file
BDBirgit van Dooijeweert
Birgit van Dooijeweert
SKSima Kheradmand Kia
Sima Kheradmand Kia
NDNiklas Dahl
Niklas Dahl
OFOdile Fenneteau
Odile Fenneteau
RLRoos Leguit
Roos Leguit
MBMarije Bartels
Marije Bartels
Diamond–Blackfan anemia (DBA) is one of the inherited bone marrow failure syndromes marked by erythroid hypoplasia. Underlying variants in ribosomal protein (RP) genes account for 80% of cases, thereby classifying DBA as a ribosomopathy. In addition to RP genes, extremely rare variants in non-RP genes, including GATA1, the master transcription factor in erythropoiesis, have been reported in recent years in patients with a DBA-like phenotype. Subsequently, a pivotal role for GATA-1 in DBA pathophysiology was established by studies showing the impaired translation of GATA1 mRNA downstream of the RP haploinsufficiency. Here, we report on a patient from the Dutch DBA registry, in which we found a novel hemizygous variant in GATA1 (c.220+2T>C), and an Iranian patient with a previously reported variant in the initiation codon of GATA1 (c.2T>C). Although clinical features were concordant with DBA, the bone marrow morphology in both patients was not typical for DBA, showing moderate erythropoietic activity with signs of dyserythropoiesis and dysmegakaryopoiesis. This motivated us to re-evaluate the clinical characteristics of previously reported cases, which resulted in the comprehensive characterization of 18 patients with an inherited GATA-1 defect in exon 2 that is presented in this case-series. In addition, we re-investigated the bone marrow aspirate of one of the previously published cases. Altogether, our observations suggest that DBA caused by GATA1 defects is characterized by distinct phenotypic characteristics, including dyserythropoiesis and dysmegakaryopoiesis, and therefore represents a distinct phenotype within the DBA disease spectrum, which might need specific clinical management.

12 July 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
CLCamille Lours
Camille Lours
LCLaurane Cottin
Laurane Cottin
MWMargaux Wiber
Margaux Wiber
VAValérie Andrieu
Valérie Andrieu
VBVéronique Baccini
Véronique Baccini
JLJean-François Lesesve
Jean-François Lesesve
In order to standardize cellular hematology practices, the French-speaking Cellular Hematology Group (Groupe Francophone d’Hématologie Cellulaire, GFHC) focused on Perls’ stain. A national survey was carried out, leading to the proposal of recommendations on insoluble iron detection and quantification in bone marrow. The criteria presented here met with a “strong professional agreement” and follow the suggestions of the World Health Organization’s classification of hematological malignancies.

20 July 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
SGSandrine Girard
Sandrine Girard
FGFranck Geneviève
Franck Geneviève
EREmmanuelle Rault
Emmanuelle Rault
OFOdile Fenneteau
Odile Fenneteau
JLJean-François Lesesve
Jean-François Lesesve
Ring sideroblasts are commonly seen in myelodysplastic neoplasms and are a key condition for identifying distinct entities of myelodysplastic neoplasms according to the WHO classification. However, the presence of ring sideroblasts is not exclusive to myelodysplastic neoplasms. Ring sideroblasts are as well either encountered in non-clonal secondary acquired disorders, such as exposure to toxic substances, drug/medicine, copper deficiency, zinc overload, lead poison, or hereditary sideroblastic anemias related to X-linked, autosomal, or mitochondrial mutations. This review article will discuss diseases associated with ring sideroblasts outside the context of myelodysplastic neoplasms. Knowledge of the differential diagnoses characterized by the presence of ring sideroblasts in bone marrow is essential to prevent any misdiagnosis, which leads to delayed diagnosis and subsequent management of patients that differ in the different forms of sideroblastic anemia.

10 September 2020 in Blood
Verified
Journal Article
Open access
PDF file
BSBérénice Schell
Bérénice Schell
OFOdile Fenneteau
Odile Fenneteau
Bérénice Schell, Odile Fenneteau; Brandalise syndrome: a rare inclusion cell disease, Blood, Volume 136, Issue 11, 10 September 2020, Pages 1373, https://doi.o